尽管对SHPT骨病的诊断和治疗有了长足的进步，仍需要更深入的研究，开发新的药物及诊断、治疗手段，以增加诊断的正确性，提高治疗的有效性。
参考文献
1 Dambacher MA，Schacht E.Osteoporosis and active vitamin D metabolite.Litera Rheumatologica，1996，18：69
2 Portale AA，Curtis Morris R.Pathogenesis of secondary hyperparathyroidism in chronic renal insufficiecy.Miner Electrolyte，1991，17：211
3 Darryl Quarles L，Lobawgh B，Murphy G.Intact parathyroid hormone overestimate the presence and severity of parathyroid-mediated osseous abnormalities in uremia.J Clin Endocrinol Metab，1992，75（1）：145
4 Cohen Solal ME，Sebert JL，Boudailliez B et al.Comparison of intact，midregion and carboxy terminal assays of parathyroid hormone for the diagnosis of bone diseases in hemodialyzed patients.J Clin Endocrinol Metab，1991，73（3）：516
5 Gerakis A，Hutchison AJ，Apostolon T et al.Biochemical markers for non-invasive diagnosis of hyperparathyroid bone diseases and adynamic bone in patients on haemodialysis.Nephrol Dial Transplant，1996，11（12）：2430
6 Torres A，Lorenzo V，Hernandez D et al.Bone disease in predialysis，hemodialysis，and CAPD patients：evidence of a better bone response to PTH.Kidney Int，1995，47（5）：1434
7 Epstein S.Serum and urinary markers of bone remodelling：assessment of bone turnover.Endocrine Rev，1988，9（4）：437
8 Seibel MJ，Rane F.Biochemical markers of bone metablism and their significance in diagnosis of osteoporosis.Clin lab，1993，39（5）：341
9 Erisen EF，Charles P，Melsen F et al.Serum markers of type Ⅰ collagen formation and degradation in metabolic bone disease：correlation with bone histomorphometry.J Bone Miner Res，1993，8：127
上一页 1 [2] 3 下一页
